BioEnlaces provides strategic consulting services to the biotechnology industry, we assist your company to achieve its business goals in new product development and commercialization. We can facilitate your strategic review process and help formulate goals that the whole company can work towards. We can act as a coordinator of your business development efforts, supplying ideas, gathering data and making contacts. We also maintain contact with an extensive network of other professionals in investor relations, financial services, legal services and various medical and business specialties.
| Website | http://www.bioenlaces.com |
| Revenue | $1 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2000 |
| Technologies | |
| Industry | Biotechnology Research |
| Keywords | Biotechnology Consulting, Strategic Consulting, Biotechnology Strategy, Product Development Consulting, Biotech Commercialization, Commercialization Consulting, Pharmaceutical Development, Biotech Partnerships, Pharmaceutical Consulting, Biotech Market Access, Life Sciences Consulting, Regulatory Affairs Consulting, Drug Development Consulting, Biotech Licensing, Biotech Due Diligence |
| Competitors | Zymergen, Inc., Geno, Amyris, Codexis, Inc., LanzaTech, BIOMILLENIA, Solugen, Novozymes, Inbiose +26 more (view full list) |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular BioEnlaces employee's phone or email?
The BioEnlaces annual revenue was $1 million in 2026.
2 people are employed at BioEnlaces.
The NAICS codes for BioEnlaces are [5417, 541711, 54, 54171, 541].